Biofil Chemicals and Pharmaceuticals reported standalone quarterly numbers for December 2024. Net Sales at Rs 14.20 crore in December 2024 up 182.13% from Rs. 5.03 crore in 2023. Net Profit at Rs. 0.16 crore in Dec 2024 up 76.31% from 0.09 crore. EBITDA stands at £0.33 crore inDec 2024 up 50% from £.0.22 crore. Biofil Chem shares closed at 50.97 on February 13, 2025 (NSE) and has given -18.29% returns over the last 6 months and -25.43% over last 12 months. The company has a market capitalization of around £1.2 billion (US$2.3 billion) and is valued at around $3 billion (U.S. dollars) The company’s share price has fallen from £2.1 billion in September 2013 to £2 billion in December 2014. The share price is now valued at about £1billion (US $2 billion)
Biofil Chemicals and Pharmaceuticals reported standalone qua….
